Fort Worth, TX, United States of America

Ronald D Schoenwald

This inventor holds 2 USPTO granted patents. Top assignee: Alcon Laboratories, Inc.. Active years: 1981-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald D Schoenwald. Retrieved from https://idiyas.com/inventor/ronald-d-schoenwald-hag57p5q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 99(Granted Patents)


Company Filing History:


Years Active: 1981-1983

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ronald D. Schoenwald

Introduction

Ronald D. Schoenwald is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of ophthalmology through his innovative inventions. With a total of 2 patents, Schoenwald has focused on developing advanced drug delivery systems for ophthalmic applications.

Latest Patents

Schoenwald's latest patents include a groundbreaking invention related to sustained release ophthalmic drug dosage. This invention is directed to an aqueous dispersion of an ophthalmic drug combined with a high molecular weight polymer. The resulting composition forms a highly viscous gel that prolongs the duration of activity of the ophthalmic drug when applied into the conjunctival sac of the eye. The gel composition has a prolonged retention time in the eye, ensuring that it remains in contact with the surface for an extended period.

Career Highlights

Throughout his career, Ronald D. Schoenwald has been associated with Alcon Laboratories, Inc., a leading company in the field of eye care. His work has contributed to advancements in ophthalmic drug formulations, enhancing the effectiveness of treatments for various eye conditions.

Collaborations

Schoenwald has collaborated with fellow inventor Robert E. Roehrs, furthering the development of innovative solutions in ophthalmology.

Conclusion

Ronald D. Schoenwald's contributions to ophthalmic drug delivery systems highlight his commitment to improving patient care. His inventions continue to influence the field and pave the way for future advancements in eye treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…